The “cheap” argument doesn’t hold up under scrutiny: governments absorbed development costs, guaranteed markets, and funded distribution entirely, meaning the cost didn’t disappear; it was shifted from pharmaceutical companies to taxpayers. Similarly, the speed was real but came at the…   Read more»